The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
Market Analysis and Insights: Global At-Home Drug of Abuse (DOA) Testing Market
The global At-Home Drug of Abuse (DOA) Testing market is projected to grow from US$ 471.1 million in 2023 to US$ 862.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Report Includes
This report presents an overview of global market for At-Home Drug of Abuse (DOA) Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of At-Home Drug of Abuse (DOA) Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for At-Home Drug of Abuse (DOA) Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the At-Home Drug of Abuse (DOA) Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global At-Home Drug of Abuse (DOA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for At-Home Drug of Abuse (DOA) Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd. and Quest Products, etc.
By Company
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Segment by Type
Test Cups
Test Dip Cards
Test Strips
Others
Segment by Application
Urine
Saliva
Hair
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of At-Home Drug of Abuse (DOA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of At-Home Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, At-Home Drug of Abuse (DOA) Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Test Cups
1.2.3 Test Dip Cards
1.2.4 Test Strips
1.2.5 Others
1.3 Market by Application
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2018-2029)
2.2 Global At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2029)
2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue At-Home Drug of Abuse (DOA) Testing by Players
3.1.1 Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2018-2023)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of At-Home Drug of Abuse (DOA) Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2022
3.5 Global Key Players of At-Home Drug of Abuse (DOA) Testing Head office and Area Served
3.6 Global Key Players of At-Home Drug of Abuse (DOA) Testing, Product and Application
3.7 Global Key Players of At-Home Drug of Abuse (DOA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2029)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2024-2029)
6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2018-2029)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2024-2029)
6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2018-2029)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
6.4.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2024-2029)
7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2018-2029)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2024-2029)
7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2018-2029)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
7.4.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
8.2 China At-Home Drug of Abuse (DOA) Testing Market Size by Type
8.2.1 China At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
8.2.2 China At-Home Drug of Abuse (DOA) Testing Market Size by Type (2024-2029)
8.2.3 China At-Home Drug of Abuse (DOA) Testing Market Share by Type (2018-2029)
8.3 China At-Home Drug of Abuse (DOA) Testing Market Size by Application
8.3.1 China At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
8.3.2 China At-Home Drug of Abuse (DOA) Testing Market Size by Application (2024-2029)
8.3.3 China At-Home Drug of Abuse (DOA) Testing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
9.2 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Type
9.2.1 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
9.2.2 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Type (2024-2029)
9.2.3 Asia At-Home Drug of Abuse (DOA) Testing Market Share by Type (2018-2029)
9.3 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Application
9.3.1 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
9.3.2 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Application (2024-2029)
9.3.3 Asia At-Home Drug of Abuse (DOA) Testing Market Share by Application (2018-2029)
9.4 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Region
9.4.1 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2023)
9.4.3 Asia At-Home Drug of Abuse (DOA) Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Details
11.1.2 UCP Biosciences Business Overview
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.1.5 UCP Biosciences Recent Developments
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Details
11.2.2 Orient New Life Medical Business Overview
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.2.5 Orient New Life Medical Recent Developments
11.3 Express Diagnostics Int’l
11.3.1 Express Diagnostics Int’l Company Details
11.3.2 Express Diagnostics Int’l Business Overview
11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.3.5 Express Diagnostics Int’l Recent Developments
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Details
11.4.2 Assure Tech (Hangzhou) Business Overview
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.4.5 Assure Tech (Hangzhou) Recent Developments
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Details
11.5.2 Psychemedics Corporation Business Overview
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.5.5 Psychemedics Corporation Recent Developments
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Details
11.6.2 Confirm BioSciences Business Overview
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.6.5 Confirm BioSciences Recent Developments
11.7 Phamatech
11.7.1 Phamatech Company Details
11.7.2 Phamatech Business Overview
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.7.5 Phamatech Recent Developments
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Details
11.8.2 Home Health (U.K.) Ltd. Business Overview
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.8.5 Home Health (U.K.) Ltd. Recent Developments
11.9 Quest Products
11.9.1 Quest Products Company Details
11.9.2 Quest Products Business Overview
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.9.5 Quest Products Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Ěý
Ěý
*If Applicable.
